Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label rollover study of ixazomib in prior Takeda ixazomib study participants
jRCT2031210531Completed
- Sponsor
- Takeda
- Start
- Dec 2016
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of ixazomib in multiple myeloma (MM), lymphoma and light-chain amyloidosis, sponsored by Takeda. Primary endpoints: Number of participants with serious adverse events (SAEs), Number of participants with Grade ≥3 adverse events and 4 more. Started Dec 2016; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)lymphomalight-chain amyloidosis
Beyond the preview
Go deeper on jRCT2031210531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210531.